FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep 3, 2025--
Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone marks continued momentum in Gilead’s multi-year strategy to drive growth and scientific leadership across virology, oncology, and inflammation, increasingly built on growing biologics capabilities. It is part of Gilead’s planned $32 billion investment in U.S. innovation through 2030. This investment is projected to generate more than $43 billion in economic value nationwide, strengthening America’s biopharmaceutical leadership while fueling high-quality jobs, research, and domestic manufacturing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903363682/en/
“This new facility is part of our vision for delivering next generation therapies and a cornerstone of Gilead’s $32 billion investment commitment in the United States,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “We have multiple construction projects underway, all of which will generate thousands of American jobs and help to drive U.S. leadership in global biopharma innovation.”
The five-story, 180,000 square foot facility will serve as a hub for innovation and collaboration across technical development and manufacturing teams. Designed with flexible pilot lab space and advanced digital infrastructure, the NTDC will accelerate technology transfer and support the advancement of next-generation biologics across Gilead’s pipeline. It will feature digitally enabled systems, autonomous robotics, and real-time digital monitoring, making it one of the most AI-enabled centers in the biopharma industry.
The new facility will strengthen Gilead’s biologics capacity and capabilities, a central pillar of the company’s growth strategy. This investment builds on Gilead’s broader U.S. efforts to expand research and manufacturing, create more than 3,000 direct and indirect high-quality jobs, and advance equitable access to healthcare nationwide.
“California is proud to be home to Gilead Sciences and its ongoing investment in innovation and jobs right here in Foster City,” said California Lieutenant Governor Eleni Kounalakis. “This new Technical Development Center is more than a milestone for Gilead; it’s a win for all who will benefit from its breakthroughs. It demonstrates that when we invest in domestic biomanufacturing, we strengthen supply chains, create thousands of good-paying jobs, and keep America at the forefront of life-saving innovation.”
This groundbreaking is part of a broader expansion at Gilead’s Foster City headquarters. In addition to the NTDC, the company is currently developing two other state-of-the-art facilities: a new research building designed to accelerate scientific discovery, already under construction, and a biologics manufacturing facility that will expand domestic production capacity. These current investments further build on Gilead’s strong history of U.S. investment, with more than $15 billion over the last decade, and reinforce the company’s role as a major contributor to the U.S. biopharmaceutical industry and a vital partner in driving scientific innovation and solutions for patients. Together, these investments form an integrated innovation ecosystem designed to accelerate discovery, streamline manufacturing, and reinforce Gilead’s role as a U.S.-based biopharma leader in improving human health globally.
Today’s event features remarks from Gilead leadership including Daniel O’Day, CEO, Stacey Ma, Executive Vice President, Pharmaceutical Development and Manufacturing, and Joydeep Ganguly, Senior Vice President, Corporate Operations. Distinguished guests include:
For more information on Gilead’s U.S. investments, visit: https://www.gilead.com/company/investing-in-the-us.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
For more information about Gilead, please visit the company’s website atwww.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
Gilead Sciences breaks ground on new manufacturing and technical development site in Bay Area.
JERUSALEM (AP) — The White House says it is moving into the second phase of President Donald Trump’s Gaza ceasefire plan – breathing new life into a proposal that aims to rebuild the war-ravaged area and reshape the wider Middle East.
Trump’s Mideast envoy, Steve Witkoff, broke the news Wednesday in a post on X, saying the new phase will include the establishment of a transitional Palestinian governing committee and begin the complicated tasks of disarming Hamas and reconstruction.
But the announcement included few details about the new Palestinian committee or other key aspects of the plan, signaling just how much work lies ahead.
Trump's 20-point plan — which was approved by the U.N. Security Council — lays out an ambitious vision for ending Hamas’ rule in Gaza. If successful, it would see the rebuilding of a demilitarized Gaza under international supervision, the normalization of relations between Israel and the Arab world, and the creation of a possible pathway to Palestinian independence.
But if the deal stalls, Gaza could be trapped in an unstable limbo for years to come, with Hamas remaining in control of parts of the territory, Israel’s army enforcing an open-ended occupation, and its residents stuck homeless, unemployed, unable to travel abroad and dependent on international aid to stay alive.
“We’re going to do our best to try and see if we can work with the Palestinian people to try something new,” said a U.S. official, speaking on condition of anonymity to discuss the evolving plan. “It will be hard to do,” he acknowledged.
Here is a closer look at the next stages of the ceasefire and the potential pitfalls.
The ceasefire took effect on Oct. 10, halting two years of fighting between Israel and Hamas. It also included the release of all remaining hostages held in Gaza in exchange for hundreds of Palestinians held by Israel.
The ceasefire has largely held, though both sides accuse each other of ongoing violations. Israeli fire has killed more than 400 Palestinians, according to Gaza health officials. Israel says it has targeted militants or responded to violations of the ceasefire, but the Palestinians say scores of civilians have been shot.
Palestinian militants, meanwhile, continue to hold the remains of the last hostage — an Israeli police officer killed in the Hamas-led Oct. 7, 2023, attack that triggered the war. Israeli Prime Minister Benjamin Netanyahu has made clear he is in no rush to move forward until the remains are returned.
Netanyahu appeared to play down Witkoff’s announcement as symbolic, calling the creation of a new Palestinian committee a “ declarative move.”
The new committee will consist of independent Palestinian experts who are to run Gaza’s daily affairs under American supervision.
Wednesday’s announcement didn't say who will serve on the committee. But the other mediators of the ceasefire — Egypt, Turkey and Qatar — said it would be led by Ali Shaath, an engineer and former deputy minister in the Palestinian Authority in the West Bank.
The U.S. official who spoke on the condition of anonymity said other names are expected in the next two days, and the committee will focus on attracting investment and improving the quality of life.
“This really will be a technocratic committee,” he said. “They seem to be a group that wants to have peace.”
The committee will report to the Board of Peace, a group of world leaders supervising the ceasefire and led by Trump. If the Palestinian committee is seen as just a façade, it risks not gaining public support.
Also, its exact powers remain unclear. Hamas has said it will dissolve its government once the committee takes office, but it has shown no signs that it will dismantle its military wing or security forces.
The board will oversee the ceasefire, reconstruction and an open-ended reform process by the Palestinian Authority, with the goal of one day allowing the internationally recognized authority to return to Gaza to govern.
The U.S. official said invitations for the board have been extended, but he declined to name any of the people expected to join. “It’s going to be a great list,” he said.
The key challenge will be forming a board that can work with Israel, Hamas, the mediators and international aid agencies.
One key appointment appears to have been made. Nickolay Mladenov, a former Bulgarian politician and U.N. Mideast envoy, is expected to serve as the board’s on-the-ground representative. He already has met with Netanyahu and Palestinian leaders in the occupied West Bank.
Trump's plan calls for the formation of an International Stabilization Force to maintain security and train Palestinian police to one day to take over. That force hasn't been formed yet, and a deployment date hasn't been announced.
The U.S. official insisted there is “great excitement” over the force and said there would be important announcements in the coming weeks.
But the force’s command structure and authorities remain unknown.
Hamas said it will oppose any attempts by the force to disarm it, and contributing nations may not to want to risk clashes with the militant group. Israel, meanwhile, is hesitant to trust an international body with its security needs.
Trump’s plan calls for an economic development outline to “rebuild and energize Gaza,” which suffered widespread destruction during the war and where most of the territory’s 2 million people are displaced and unemployed.
Still, no such plan has been announced, and it remains unclear who will pay for a process the U.N. estimates will cost $70 billion.
The ceasefire deal calls for Hamas to surrender its weapons under the supervision of international monitors. Militants who disarm will be granted amnesty and the option to leave Gaza.
However, Hamas, whose ideology is based on armed resistance against Israel, has said it won't disarm until Israel ends its occupation of Palestinian territories.
Bassem Naim, a senior Hamas official, told The Associated Press last month that the group is open to “ freezing or storing” its weapons while a political process takes place, perhaps over many years. It is unclear whether that would be sufficient for Israel.
Failure to disarm Hamas could lead to renewed fighting with Israel and clashes with international troops, and could block progress on the rest of the peace plan.
Under the ceasefire, Israel is to withdraw from all of Gaza, with the exception of a small buffer zone along the border. At the moment, Israel retains control of just over half of Gaza.
The plan says further withdrawals will be based upon “standards, milestones and timeframes linked to demilitarization” to be negotiated by Israel, the U.S., the international force and other “guarantors.”
There are no firm timelines for further withdrawals, and Israel may refuse to pull back further.
The plan calls for an overhaul of the Palestinian Authority, which runs the West Bank, and the creation of conditions for a “credible pathway” to Palestinian statehood.
Palestinian officials say they have begun making reforms in key areas such as corruption, the education system and payments to families of prisoners convicted in attacks on Israelis.
Israel rejects the creation of a Palestinian state and opposes any role for the authority in postwar Gaza. Without a pathway to statehood, any Palestinian support for the new system could crumble. The plan also offers no clear benchmarks or timelines for the reform process.
US Special Envoy Steve Witkoff delivers a speech upon the signing of the declaration on deploying post-ceasefire force in Ukraine during the 'Coalition of the Willing' summit on security guarantees for Ukraine, at the Elysee Palace in Paris Tuesday, Jan 6, 2026. (Ludovic Marin, Pool photo via AP)
Palestinians walk amid buildings destroyed by Israeli air and ground operations in Gaza City Thursday, Jan. 15, 2026. (AP Photo/Jehad Alshrafi)
Makeshift tents shelter displaced Palestinians stand among buildings destroyed by Israeli air and ground operations in Gaza City Thursday, Jan. 15, 2026. (AP Photo/Jehad Alshrafi)
